Mental Training for CFS Following EBV Infection in Adolescents

Sponsor
University Hospital, Akershus (Other)
Overall Status
Completed
CT.gov ID
NCT02499302
Collaborator
(none)
50
1
2
36
1.4

Study Details

Study Description

Brief Summary

The general aim of this study is to investigate the effect of an individually tailored mental training program in adolescents developing chronic fatigue syndrome (CFS) after an acute Epstein Barr-virus (EBV) infection. Endpoints include physical activity (primary endpoint), symptoms (fatigue, pain, insomnia), cognitive function (executive functions) and markers of disease mechanisms (autonomic, endocrine, and immune responses).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mental training
N/A

Detailed Description

EBV-infection is a well-known trigger of CFS. A closely related research project (Chronic fatigue following acute Epstein-Barr virus infection in Adolescents; ClinicalTrials ID:NCT02335437) is a combined prospective and cross-sectional study of 200 adolescents suffering from acute EBV infection. The primary aim of that study is to identify factors that predispose to CFS 6 months after the acute infection. Thus, that project will provide a sample of thoroughly characterized CFS patients, all having the same precipitation factor (EBV-infection).

The present project is an intervention trial in the subgroup of patients that actually did develop CFS 6 months after the acute EBV infection. Patients will be randomised 1:1 to either a mental training program (10 sessions) combining elements from cognitive behavioral therapy and music therapy, or routine follow-up from the general practitioner. By its nature, treatment group allocation cannot be blinded; however, both patients and therapists will be blinded for end-point evaluation. An extensive investigational program will be carried out at three time points: Prior to the intervention, immediately after the intervention, and 1 year after the intervention. The program includes: Clinical examination; Pain threshold assessment; Cardiovascular assessment; Cognitive assessment; Sampling of biological material (blood and urine); Questionnaire; Brain fMRI; Qualitative interview; Monitoring of physical activity (accelerometer)

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Mental Training for Chronic Fatigue Syndrome (CFS/ME) Following EBV Infection in Adolescents: A Randomised Controlled Trial
Actual Study Start Date :
Oct 1, 2015
Actual Primary Completion Date :
Oct 1, 2017
Actual Study Completion Date :
Oct 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mental training

The intervention consists of one introductory session (patients and their parents/next-of-kin), followed by 9 individual therapy sessions (one each week) of 1.5 hours duration and related home-work, combining elements from cognitive behavioural therapy and music therapy: Important elements of the mental training program are: Psychoeducation: Theories of CFS/ME pathophysiology and treatment rationale Relaxation: Bodily stress reduction, mindfulness Visualization: Contact with positive emotions, techniques of worrying reduction Experiences: Behavioral 'experiments' (individually adjusted), 'trick into action' Cognitive challenges: Challenging thoughts about disease process, stimulus and outcome expectancies, prognosis

Behavioral: Mental training

No Intervention: Routine follow-up

Routine follow-up by the general practitioner, which is normal approach to chronic fatigue following acute EBV infection.

Outcome Measures

Primary Outcome Measures

  1. Physical activity [12 weeks]

    Mean steps/day during 7 consecutive days measured by accelerometer

Secondary Outcome Measures

  1. Plasma catecholamines [12 weeks]

  2. Plasma catecholamines [64 weeks]

  3. Urine cortisol:creatinin ratio [12 weeks]

  4. Urine cortisol:creatinin ratio [64 weeks]

  5. Degree centrality index of cytokine network [12 weeks]

    An index of node centrality, based upon network analyses

  6. Degree centrality index of cytokine network [64 weeks]

    An index of node centrality, based upon network analyses

  7. Number of NK-cells [12 weeks]

  8. Number of NK-cells [64 weeks]

  9. Supine heart rate [12 weeks]

  10. Supine heart rate [64 weeks]

  11. Heart rate variability indices [12 weeks]

  12. Heart rate variability indices [64 weeks]

  13. Heart rate, blood pressure and total peripheral resistence responses to upright posture [12 weeks]

  14. Heart rate, blood pressure and total peripheral resistence responses to upright posture [64 weeks]

  15. Working memory [12 weeks]

    Digit span forward and backward test

  16. Working memory [64 weeks]

    Digit span forward and backward test

  17. Cognitive inhibition [12 weeks]

    Color-word interference test from the D-KEFS instrument

  18. Cognitive inhibition [64 weeks]

    Color-word interference test from the D-KEFS instrument

  19. Correlation matrix indices of regions of interests (ROIs) in the brain salience network [12 weeks]

    Functional connectivity analyses from resting state brain fMRI

  20. Correlation matrix indices of regions of interests (ROIs) in the brain salience network [64 weeks]

    Functional connectivity analyses from resting state brain fMRI

  21. Fatigue score (Chalder fatigue questionnaire) [12 weeks]

  22. Fatigue score (Chalder fatigue questionnaire) [64 weeks]

  23. Pain scores (Brief pain Inventory) [12 weeks]

  24. Pain scores (Brief pain Inventory) [64 weeks]

  25. Quality of Life score (PedsQL) [12 weeks]

  26. Quality of Life score (PedsQL) [64 weeks]

  27. Anxiety and depression score (HADS) [12 weeks]

  28. Anxiety and depression score (HADS) [64 weeks]

  29. Alexithymia score (TAS-20) [12 weeks]

  30. Alexithymia score (TAS-20) [64 weeks]

  31. Insomnia score (KSQ) [12 weeks]

  32. Insomnia score (KSQ) [64 weeks]

  33. Pain threshold (algometry) [12 weeks]

  34. Pain threshold (algometry) [64 weeks]

  35. Disability score (FDI) [12 weeks]

  36. Disability score (FDI) [64 weeks]

  37. Side effect and unexpected events questionnaire [3 weeks]

  38. Side effect and unexpected events questionnaire [6 weeks]

  39. Side effect and unexpected events questionnaire [9 weeks]

  40. Side effect and unexpected events questionnaire [12 weeks]

  41. Physical activity [64 weeks]

    Mean steps/day during 7 consecutive days measured by accelerometer

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 20 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participant in the research project CEBA (Chronic fatigue following acute Epstein-Barr virus infection in adolescents, NCT02335437)

  • Chronic fatigue at 6 months (a sum score of dichotomized responses ≥ 4 on the Chalder Fatigue questionnaire)

Exclusion Criteria:
  • Other illnesses that might explain the fatigue

  • Bedridden

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dept. of Pediatrics, Akershus University Hospital Lørenskog Akershus Norway N-1478

Sponsors and Collaborators

  • University Hospital, Akershus

Investigators

  • Principal Investigator: Vegard Bruun Wyller, PhD, University Hospital, Akershus

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Vegard Wyller, Professor, University Hospital, Akershus
ClinicalTrials.gov Identifier:
NCT02499302
Other Study ID Numbers:
  • CEBA part 2
First Posted:
Jul 16, 2015
Last Update Posted:
Feb 16, 2022
Last Verified:
Feb 1, 2022

Study Results

No Results Posted as of Feb 16, 2022